Blood Inhibition Resistant Mutants of Taq DNA Polymerase

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43GM073401-01
Agency Tracking Number: GM073401
Amount: $107,144.00
Phase: Phase I
Program: SBIR
Awards Year: 2005
Solicitation Year: 2005
Solicitation Topic Code: N/A
Solicitation Number: PHS2005-2
Small Business Information
Dna Polymerase Technology, Inc., 1508 S Grand Blvd, St. Louis, MO, 63104
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 MILKO KERMEKCHIEV
 (314) 771-5566
 MILKO@KLENTAQ.COM
Business Contact
 WAYNE BARNES
Phone: (314) 771-5566
Email: WAYNE@KLENTAQ.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The success and sensitivity of DNA detection is limited in important clinical, forensic, and environmental applications due to the presence of complex biological samples, such as blood, which reduce amplification efficiency. Different pre-PCR treatments that are being used to overcome this inhibitory effect in crude specimens significantly increase the duration and cost of the tests. We propose to develop and functionally characterize Taq polymerase mutants resistant to the blood inhibitory effect, which would allow a faster and lower-cost PCR analysis of crude samples. We also plan to obtain mutants of Taq with rapid DNA elongation, which will reduce the time of the amplification cycle, and we will attempt to add this feature to the blood-resistant phenotype. The screening for the above mutants will be performed by directed evolution of mutagenized Taq enzyme, using a high throughput version of this strategy, through which thousands of mutant clones are simultaneously amplified in individual micro-compartments of an emulsion PCR mixture. This proposal was motivated by our initial data showing that the two desired features of Taq, high resistance to blood inhibition and faster DNA elongation, are indeed obtainable by mutagenesis. Finally, in a potential phase two of the project, we will try to combine these two novel qualities of Taq with the cold-sensitive mutants of the enzyme designed for hot-start PCR which have already been developed and marketed by our company.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government